1 / 20

manatt

manatt. A U.S. Perspective Commonwealth Fund Alliance for Health Reform November 7, 2011 Ian D. Spatz. Points to make. The U.S. is Different Search for Value Already Underway in U.S. Success Depends on Investment in Generating Data, Not Just Analyzing Data. Points to make.

clamoureux
Download Presentation

manatt

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. manatt A U.S. PerspectiveCommonwealth FundAlliance for Health ReformNovember 7, 2011Ian D. Spatz

  2. Points to make The U.S. is Different Search for Value Already Underway in U.S. Success Depends on Investment in Generating Data, Not Just Analyzing Data

  3. Points to make The U.S. is Different Search for Value Already Underway in U.S. Success Depends on Investment in Generating Data, Not Just Analyzing Data

  4. Wine Consumption Source:  2009 Wine Institute 45.23 liters 45.23 Liters 24.44 Liters 20.72 Liters 8.96 Liters

  5. Beer Consumption Source: FAOstat (UN) 27.36 liters 102.24 Liters 102.24 liters 99.83 liters 86.08 liters

  6. Obesity Source:  OECD Health Data 2005 Percentage of population with BMI>30 9.4% 12.9% 23% 30.6%

  7. CT Scan Abdomen Source:  International Federation of Health Plans, 2010 (U.S. avg.) $179 $374 $187 $536

  8. Bypass Surgery Source:  International Federation of Health Plans, 2010 (U.S. avg.) $16,325 $27,327 $13.998 $59,770

  9. Cost Effectiveness

  10. Cost Effectiveness Comparative Effectiveness

  11. Cost Effectiveness Comparative Effectiveness Patient-Centered Outcome Research

  12. Points to make The U.S. is Different Search for Value Already Underway in U.S. Success Depends on Investment in Generating Data, Not Just Analyzing Data

  13. Express Scripts CVS/Caremark Germany France Medco UK MedImpact 90 million 85.1 million 81.5 million 65 million 65 million 63 million 32 million Large, Empowered Payers Atlantic Information Services, 2010

  14. Multi-tier formularies Generic substitution Prior authorization Generics first Drug utilization review Risk sharing

  15. Points to make The U.S. is Different Search for Value Already Underway in U.S. Success Depends on Investment in Generating Data, Not Just Analyzing Data

  16. “Whether the addition of [product] to chemotherapy regimens for [type of cancer] improves health outcomes has not been established.” “It was not certain whether [product] provides enough benefit to patients to justify its high cost …, so NICE did not recommend it.” “We don’t know” “We know it doesn’t help”

  17. Starting in 2013, Medicare and all private health insurance companies will pay a tax into a trust fund that will support the activities of the Patient-Centered Outcomes Research Institute Funding is estimated to reach $500 million annually by 2015

  18. Points to make The U.S. is Different Search for Value Already Underway in U.S. Success Depends on Investment in Generating Data, Not Just Analyzing Data

More Related